Liu P - Search Results

1

Six new phenolic glycosides from the roots of Scrophularia ningpoensis.

Li YC, Liu P, Su YY, Xu C, Sun M, Zhang W, Liu B. Li YC, et al. Among authors: liu b, liu p. Fitoterapia. 2024 Dec;179:106258. doi: 10.1016/j.fitote.2024.106258. Epub 2024 Oct 16. Fitoterapia. 2024. PMID: 39419125

2

pH/Ion Dual-Responsive Emulsion Via a Cationic Surfactant and Positively Charged Magnesium Hydroxide Nanosheets.

Zhu P, Chen J, Ding Y, Liu P, Fan H, Yang M. Zhu P, et al. Among authors: liu p. Langmuir. 2024 Mar 12;40(10):5360-5368. doi: 10.1021/acs.langmuir.3c03830. Epub 2024 Mar 1. Langmuir. 2024. PMID: 38427799

3

The Clinical Characteristics and Potential Molecular Mechanism of LMNA Mutation-Related Lipodystrophy.

Xiao C, Liu J, Yang C, Zhai X, Liu P, Xiao X, Yu M. Xiao C, et al. Among authors: liu j, liu p. Adv Biol (Weinh). 2023 Sep;7(9):e2200301. doi: 10.1002/adbi.202200301. Epub 2023 Jun 11. Adv Biol (Weinh). 2023. PMID: 37303127

4

DCZ0801, a novel compound, induces cell apoptosis and cell cycle arrest via MAPK pathway in multiple myeloma.

Zhang T, Li B, Feng Q, Xu Z, Huang C, Wu H, Chen Z, Hu L, Gao L, Liu P, Yang G, Zhang H, Lu K, Li T, Tao Y, Wu X, Shi J, Zhu W. Zhang T, et al. Among authors: liu p. Acta Biochim Biophys Sin (Shanghai). 2019 May 23;51(5):517-523. doi: 10.1093/abbs/gmz033. Acta Biochim Biophys Sin (Shanghai). 2019. PMID: 30947332 Free article.

5

Author Correction: DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer.

Chen XL, Liu P, Zhu WL, Lou LG. Chen XL, et al. Among authors: liu p. Acta Pharmacol Sin. 2024 Mar;45(3):660. doi: 10.1038/s41401-023-01184-6. Acta Pharmacol Sin. 2024. PMID: 38012293 Free article. No abstract available.

6

Chemotherapy-induced phlebitis via the GBP5/NLRP3 inflammasome axis and the therapeutic effect of aescin.

Liu P, Ye L, Ren Y, Zhao G, Zhang Y, Lu S, Li Q, Wu C, Bai L, Zhang Z, Zhao Z, Shi Z, Yin S, Liao M, Lan Z, Feng J, Chen L. Liu P, et al. Br J Pharmacol. 2023 Apr;180(8):1132-1147. doi: 10.1111/bph.16002. Epub 2022 Dec 26. Br J Pharmacol. 2023. PMID: 36479683 Free article.

7

Design, Synthesis and Pharmacological Evaluation of Novel Hsp90N-terminal Inhibitors Without Induction of Heat Shock Response.

Liu P, Chen X, Zhu J, Li B, Chen Z, Wang G, Sun H, Xu Z, Zhao Z, Zhou C, Xie C, Lou L, Zhu W. Liu P, et al. ChemistryOpen. 2019 Mar 28;8(3):344-353. doi: 10.1002/open.201900055. eCollection 2019 Mar. ChemistryOpen. 2019. PMID: 30976475 Free PMC article.

8

DCZ5248, a novel dual inhibitor of Hsp90 and autophagy, exerts antitumor activity against colon cancer.

Chen XL, Liu P, Zhu WL, Lou LG. Chen XL, et al. Among authors: liu p. Acta Pharmacol Sin. 2021 Jan;42(1):132-141. doi: 10.1038/s41401-020-0398-2. Epub 2020 May 13. Acta Pharmacol Sin. 2021. PMID: 32404982 Free PMC article.

9

Dual inhibition of mTORC1/2 by DCZ0358 induces cytotoxicity in multiple myeloma and overcomes the protective effect of the bone marrow microenvironment.

Gao L, Li B, Yang G, Liu P, Lan X, Chang S, Tao Y, Xu Z, Xie B, Sun X, Wang Y, Hu L, Yu D, Xie Y, Bu W, Wu X, Zhu W, Shi J. Gao L, et al. Among authors: liu p. Cancer Lett. 2018 May 1;421:135-144. doi: 10.1016/j.canlet.2018.02.009. Epub 2018 Feb 9. Cancer Lett. 2018. PMID: 29428642

10

DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction.

Chen X, Liu P, Wang Q, Li Y, Fu L, Fu H, Zhu J, Chen Z, Zhu W, Xie C, Lou L. Chen X, et al. Among authors: liu p. Cancer Lett. 2018 Oct 10;434:70-80. doi: 10.1016/j.canlet.2018.07.012. Epub 2018 Jul 11. Cancer Lett. 2018. PMID: 30017966

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,171 results

Search Page

Filters